by editor | Apr 1, 2020 | Top Page Links
On Monday, March 30, Rush Limbaugh read an excerpt from a Wall Street Journal op-ed by Dr. Jeff Colyer describing his experience treating COVID-19 patients in Kansas City with a combination of hydroxychloroquine and azithromycin. ...
by editor | Apr 1, 2020 | Top Page Links
There is growing interest in a drug usually prescribed for malaria or lupus, hydroxychloroquine, as a potential treatment for the COVID-19/novel coronavirus now circling the globe. In recent weeks doctors in Kansas City have reported positive results with...
by editor | Mar 31, 2020 | Top Page Links
By Daniel McGroarty, GeoPolicy Editor Imagine a door handle that can attack the COVID-19 virus on a molecular level, destroying it within a few hours. Imagine a mask that can capture and kill COVID droplets. Imagine pillowcases and hospital gowns that destroy...
by editor | Mar 31, 2020 | Top Page Links
Writing for Business Insider, health policy communications thought leader Jove Oliver warns that in addition to the deadly threat of the virus, we face a related threat in the form of the cloud of disinformation and fake news emanating from obscure sources...
by editor | Mar 29, 2020 | Top Page Links
Dr. Jeff Colyer is back with another piece in the Wall Street Journal providing an update on COVID-19 patients being treated with a combination of the drugs hydroxychloroquine (HC) and azithromycin (more commonly known as Z-Pak). Newly emerging data are showing more...
by editor | Mar 27, 2020 | Top Page Links
The outcome of the world’s response to COVID-19 depends largely on the success of longstanding research and development (R&D) partnerships between public and private sector institutions, including national governments, universities, and pharmaceutical...
